Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival

Virchows Archiv

Volumn 461, Issue 1, 2012, Pages 33-39

  Williams, Emma ^a   Martin, Stewart ^b   Moss, Robert ^b   Durrant, Lindy ^b   Deen, Suha ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Carbonic anhydrase; Ovarian cancer; Serous carcinoma; VEGF

Indexed keywords

ANTINEOPLASTIC AGENT; CARBONATE DEHYDRATASE IX; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARIAN SEROUS CARCINOMA; OVARY CARCINOMA; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CELL HYPOXIA; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864265658     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1252-9     Document Type: Article

References (33)

1. D Westfall AA Roma EG Silva 2009 High-grade serous carcinoma of the ovary Ann Diagn Pathol 13 4 285 290 19608089 10.1016/j.anndiagpath.2009.03.005
2. RA Burger 2011 Overview of anti-angiogenic agents in development for ovarian cancer Gynecol Oncol 121 230 238 21215996 10.1016/j.ygyno.2010.11.035 1:CAS:528:DC%2BC3MXjs1Wrs7o%3D
3. GL Semenza 2001 Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance J Clin Invest 108 39 40 11435455 1:CAS:528: DC%2BD3MXkvVars78%3D
4. JE Ziello IS Jovin Y Huang 2007 Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia Yale J Biol Med 80 2 51 60 18160990 1:CAS:528:DC%2BD1cXisFKgsbk%3D
5. K Ruan G Song G Ouyang 2009 Role of hypoxia in the hallmarks of human cancer J Cell Biochem 107 1053 1062 19479945 10.1002/jcb.22214 1:CAS:528:DC%2BD1MXptlOnuro%3D
6. CC Wykoff NJ Beasley PH Watson, et al. 2000 Hypoxia-inducible expression of tumour-associated carbonic anhydrases Cancer Res 60 7075 7083 11156414 1:CAS:528:DC%2BD3MXjsVOhtw%3D%3D
7. AM Shannon DJ Bouchier-Hayes CM Condron, et al. 2003 Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies Cancer Treat Rev 29 4 297 307 12927570 10.1016/S0305-7372(03)00003-3 1:CAS:528:DC%2BD3sXmsVCns7Y%3D
8. CPS Potter AL Harris 2003 Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer Br J Cancer 89 2 7 12838292 10.1038/sj.bjc.6600936 1:CAS:528:DC%2BD3sXltVWms7k%3D
9. M Hockel K Schlenger B Aral, et al. 1996 Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 4509 4515 8813149 1:STN:280:DyaK28vgvVWjtg%3D%3D
10. DM Brizel SP Scully JM Harrelson, et al. 1996 Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 941 943 8640781 1:CAS:528:DyaK28XhtlKks7Y%3D
11. BP Mahoney N Raghunand B Baggett, et al. 2003 Tumor acidity, ion trapping and chemotherapeutics I. Acid pH affects the distribution of chemotherapeutic agents in vitro Biochem Pharmacol 66 1207 1218 14505800 10.1016/S0006-2952(03) 00467-2 1:CAS:528:DC%2BD3sXnsVams7k%3D
12. SA Hussain R Ganesan G Reynolds, et al. 2007 Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer Br J Cancer 96 1 104 109 17213826 10.1038/sj.bjc.6603530 1:CAS:528:DC%2BD2sXis1KnsQ%3D%3D
13. JA Loncaster AL Harris SE Davidson, et al. 2001 Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumour oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res 61 17 6394 6399 11522632 1:CAS:528:DC%2BD3MXmsF2jsLo%3D
14. SJ Kim ZN Rabbani MW Dewhirst, et al. 2005 Expression of HIF-1α, CA IX, VEGF and MMP-9 in surgically resected non-small cell lung cancer Lung Cancer 49 3 325 335 15935515 10.1016/j.lungcan.2005.03.036
15. A Driessen W Landuyt S Pastorekova, et al. 2006 Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas Ann Surg 243 334 340 16495697 10.1097/01.sla.0000201452.09591.f3
16. EP Hui ATC Chan F Pezzella, et al. 2002 Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival Clin Cancer Res 8 2595 2604 12171890 1:CAS:528:DC%2BD38XmvVahsL8%3D
17. P Hynninen L Vaskivuo J Saarnio, et al. 2006 Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours Histopathology 49 594 602 17163844 10.1111/j.1365-2559.2006.02523.x 1:STN:280:DC%2BD28jis1WlsA%3D%3D
18. EA Eisenhauer P Therasse J Bagaerts, et al. 2009 New response evaluation criteria in solid tumors: revised RECIT guideline (Version 1.1) Eur J Cancer 45 228 247 19097774 10.1016/j.ejca.2008.10.026 1:STN:280:DC%2BD1M%2Fgs12rug%3D%3D
19. M Markman W Hoskins 1992 Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population J Clin Oncol 10 4 513 514 1548513 1:STN:280:DyaK387ptl2mtw%3D%3D
20. DG Rosen X Huang MT Deavers, et al. 2004 Validation of tissue microarray technology in ovarian carcinoma Mod Pathol 17 790 797 15073602 10.1038/modpathol.3800120 1:CAS:528:DC%2BD2cXmsVOis7s%3D
21. RL Camp LA Charette DL Rimm 2000 Validation of tissue microarray technology in breast carcinoma Lab Invest 80 12 1943 1949 11140706 10.1038/labinvest.3780204 1:STN:280:DC%2BD3M%2Foslamsg%3D%3D
22. J Kononen L Bubendorf A Kallioniemi, et al. 1998 Tissue microarrays for high-throughput molecular profiling of tumour specimens Nat Med 4 844 847 9662379 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D
23. D Shibata WJ Martin N Arnheim 1988 Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology Cancer Res 48 4564 4566 2840197 1:CAS:528:DyaL1cXlt1Ghsr8%3D
24. KS McCarty Jr LS Miller EB Cox, et al. 1985 Estrogen receptor analyses. Correlation of biochemical and immuno-histochemical methods using monoclonal antireceptor antibodies Arch Pathol Lab Med 109 716 721 3893381
25. RL Camp M Dolled-Filhart DL Rimm 2004 X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252 7259 15534099 10.1158/1078-0432.CCR-04-0713 1:CAS:528: DC%2BD2cXpsVKltbc%3D
26. NB Phuoc H Ehara T Gotoh, et al. 2008 Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma Oncol Rep 20 525 530 18695901
27. TJ Duncan A Al-Attar P Rolland, et al. 2008 Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies? Clin Cancer Res 14 10 3030 3035 18483368 10.1158/1078-0432.CCR-07- 1888 1:CAS:528:DC%2BD1cXmtVCmtb4%3D
28. S Greenberg HS Rugo 2010 Triple-negative breast cancer: role of antiangiogenic agents Cancer J 16 1 33 38 20164688 10.1097/PPO.0b013e3181d38514 1:CAS:528:DC%2BC3cXjvVKkt7c%3D
29. E Sivridis A Giatromanolaki KC Gatter, et al. 2002 Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma Cancer 95 5 1055 63 12209691 10.1002/cncr.10774 1:CAS:528:DC%2BD38XntlSrtLk%3D
30. J Saarnio S Parkkila A Parkkila, et al. 1998 Immunohistochemical study of colorectal tumour for expression of a novel transmembrane carbonic anhydrase MN/CA IX, with potential value as a marker of cell proliferation Am J Pathol 153 1 279 285 9665489 10.1016/S0002-9440(10)65569-1 1:CAS:528:DyaK1cXks1GrsbY%3D
31. P Birner M Schindl A Obermair, et al. 2001 Expression of hypoxia-inducible factor 1a in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy Clin Cancer Res 7 1661 1668 11410504 1:CAS:528:DC%2BD3MXltV2hs74%3D
32. BG Wouters SA Weppler M Koritzinsky, et al. 2002 Hypoxia as a target for combined modality treatments Eur J Cancer 38 240 257 11803141 10.1016/S0959-8049(01)00361-6 1:STN:280:DC%2BD38%2Fns1Omtw%3D%3D
33. AM Jubb TQ Pham AM Hanby, et al. 2004 Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours J Clin Pathol 57 504 512 15113858 10.1136/jcp.2003.012963 1:CAS:528:DC%2BD2cXmtl2qurk%3D